Keywords: connetics, start, ph, iii, program, steroid, corp

Connetics start Ph III program for steroid

Article | 04 April 2005

Connetics Corp, a California, USA-based specialty pharmaceutical firm that develops and commercializes dermatology products, has initiated a Phase III clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Clobetasol Propionate

Olux

Go to drug listing